Global Multiple Myeloma Epidemiology and Patient Flow Analysis - 2018

  • ID: 4516297
  • Report
  • Region: Global
  • Fore Pharma
20 % OFF
until Dec 31st 2018
1 of 3
The researcher announced the results of its Multiple Myeloma patients study in a new research ‘Global Multiple Myeloma Epidemiology and Patient Flow Analysis - 2018’. The research provides insights into Multiple Myeloma epidemiology, Multiple Myeloma diagnosed patients, and Multiple Myeloma treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of Multiple Myeloma derived from epidemiological analysis, patients diagnosed with Multiple Myeloma, and patients treated with a drug therapy.

The research study helps executives estimate Multiple Myeloma market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Multiple Myeloma prevalence, Multiple Myeloma diagnosis rate, and Multiple Myeloma treatment rate for the period 2017 - 2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.

Key Features of the Report:
  • Multiple Myeloma Patient Flow
  • Multiple Myeloma Prevalence
  • Multiple Myeloma Diagnosed Patients
  • Multiple Myeloma Treated Patients
Note: Product cover images may vary from those shown
2 of 3
1. Multiple Myeloma: Disease Definition
2. Global Multiple Myeloma Patient Flow
2A. Global Multiple Myeloma Prevalence
2B. Global Multiple Myeloma Diagnosed Patients
2C. Global Multiple Myeloma Treated Patients
3. Multiple Myeloma Patient Flow in the US
3A. Multiple Myeloma Prevalence in the US
3B. Multiple Myeloma Diagnosed Patients in the US
3C. Multiple Myeloma Treated Patients in the US
4. Multiple Myeloma Patient Flow in Europe
4A. Multiple Myeloma Prevalence in Europe
4B. Multiple Myeloma Diagnosed Patients in Europe
4C. Multiple Myeloma Treated Patients in Europe
5. Multiple Myeloma Patient Flow in Germany
5A. Multiple Myeloma Prevalence in Germany
5B. Multiple Myeloma Diagnosed Patients in Germany
5C. Multiple Myeloma Treated Patients in Germany
6. Multiple Myeloma Patient Flow in France
6A. Multiple Myeloma Prevalence in France
6B. Multiple Myeloma Diagnosed Patients in France
6C. Multiple Myeloma Treated Patients in France
7. Multiple Myeloma Patient Flow in Spain
7A. Multiple Myeloma Prevalence in Spain
7B. Multiple Myeloma Diagnosed Patients in Spain
7C. Multiple Myeloma Treated Patients in Spain
8. Multiple Myeloma Patient Flow in Italy
8A. Multiple Myeloma Prevalence in Italy
8B. Multiple Myeloma Diagnosed Patients in Italy
8C. Multiple Myeloma Treated Patients in Italy
9. Multiple Myeloma Patient Flow in UK
9A. Multiple Myeloma Prevalence in UK
9B. Multiple Myeloma Diagnosed Patients in UK
9C. Multiple Myeloma Treated Patients in UK
10. Multiple Myeloma Patient Flow in Japan
10A. Multiple Myeloma Prevalence in Japan
10B. Multiple Myeloma Diagnosed Patients in Japan
10C. Multiple Myeloma Treated Patients in Japan
11. Research Methodology

List of Tables
Table 1: Global Multiple Myeloma Patient Flow, 2017
Table 2: Global Multiple Myeloma Patient Flow Forecast, 2017 - 2026
Table 3: Multiple Myeloma Patient Flow in the US, 2017
Table 4: Multiple Myeloma Patient Flow Forecast in the US, 2017 - 2026
Table 5: Multiple Myeloma Patient Flow in Europe, 2017
Table 6: Multiple Myeloma Patient Flow Forecast in Europe, 2017 - 2026
Table 7: Multiple Myeloma Patient Flow in Germany, 2017
Table 8: Multiple Myeloma Patient Flow Forecast in Germany, 2017 - 2026
Table 9: Multiple Myeloma Patient Flow in France, 2017
Table 10: Multiple Myeloma Patient Flow Forecast in France, 2017 - 2026
Table 11: Multiple Myeloma Patient Flow in Spain, 2017
Table 12: Multiple Myeloma Patient Flow Forecast in Spain, 2017 - 2026
Table 13: Multiple Myeloma Patient Flow in Italy, 2017
Table 14: Multiple Myeloma Patient Flow Forecast in Italy, 2017 - 2026
Table 15: Multiple Myeloma Patient Flow in UK, 2017
Table 16: Multiple Myeloma Patient Flow Forecast in UK, 2017 - 2026
Table 17: Multiple Myeloma Patient Flow in Japan, 2017
Table 18: Multiple Myeloma Patient Flow Forecast in Japan, 2017 - 2026

List of Figures
Figures 1: Global Multiple Myeloma Patient Flow, 2017
Figure 2: Global Multiple Myeloma Patient Flow Forecast, 2017 - 2026
Figure 3: Multiple Myeloma Patient Flow in the US, 2017
Figure 4: Multiple Myeloma Patient Flow Forecast in the US, 2017 - 2026
Figure 5: Multiple Myeloma Patient Flow in Europe, 2017
Figure 6: Multiple Myeloma Patient Flow Forecast in Europe, 2017 - 2026
Figure 7: Multiple Myeloma Patient Flow in Germany, 2017
Figure 8: Multiple Myeloma Patient Flow Forecast in Germany, 2017 - 2026
Figure 9: Multiple Myeloma Patient Flow in France, 2017
Figure 10: Multiple Myeloma Patient Flow Forecast in France, 2017 - 2026
Figure 11: Multiple Myeloma Patient Flow in Spain, 2017
Figure 12: Multiple Myeloma Patient Flow Forecast in Spain, 2017 - 2026
Figure 13: Multiple Myeloma Patient Flow in Italy, 2017
Figure 14: Multiple Myeloma Patient Flow Forecast in Italy, 2017 - 2026
Figure 15: Multiple Myeloma Patient Flow in UK, 2017
Figure 16: Multiple Myeloma Patient Flow Forecast in UK, 2017 - 2026
Figure 17: Multiple Myeloma Patient Flow in Japan, 2017
Figure 18: Multiple Myeloma Patient Flow Forecast in Japan, 2017 - 2026
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll